Medicilon owns one of the biggest animal facilities in Shanghai. The animal facility with total 50,000 square feet has been accreditated by AAALAC. In addition, Non-Human Primate Experimental Platform has been authorized by Shanghai government.

Medicilon preclinical research scientists have advanced capabilities in the area of drug metabolism/pharmacokinetics, efficacy studies, as well as general toxicology. The company offers high quality data and a rapid turnaround time to support your discovery, preclinical and clinical studies. The company provides comprehensive services that cover all aspects of your research: study design, protocol design and writing, in-life study, sample analysis, expert data analysis, IACUC review management, report preparation and writing.

The preclinical team at Medicilon works closely with our medicinal chemists and biologists to efficiently incorporate desired properties into compounds to transform them into drug candidates ready for clinical trials.